Related Experiment Video
Updated: Jun 8, 2026

Optimized Protocols for Mycobacterium leprae Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice
Published on: March 23, 2014
Disability in leprosy patients after MDT
1Departments of PSM, Institute of Medical Sciences, BHU, Varanasi-221001, India.
Abstract:
Disabilities continue to develop and increase in severity with dapsone monotherapy. This study shows the impact of MDT on disabilities. We interviewed the patients of Chiraigaon block (population,185,521) who had completed MDT under NLEP. There had been significant increase in number of patients with grade-ll and III disability during the course of MDT. This could have been reduced if regular disability examination was done. Long lag period between the onset of disease and start of MDT was an important reason for high disability rate.
Insights
Dapsone monotherapy can worsen disabilities. Multidrug therapy (MDT) showed an increase in severe disabilities, highlighting the need for regular disability checks and prompt MDT initiation to prevent worsening leprosy outcomes.
Area of Science:
- Medical Research
- Public Health
- Leprosy Studies
Background:
- Dapsone monotherapy is associated with progressive disabilities in leprosy patients.
- Leprosy management strategies aim to prevent and reduce disability.
- The National Leprosy Eradication Programme (NLEP) utilizes multidrug therapy (MDT).
Purpose of the Study:
- To evaluate the impact of multidrug therapy (MDT) on disability progression in leprosy patients.
- To identify factors contributing to disability during leprosy treatment.
Main Methods:
- A study was conducted in the Chiraigaon block involving patients who completed MDT under NLEP.
- Patient interviews were conducted to gather data on disability status.
- Analysis focused on disability grading (Grade II and III) during MDT.
Main Results:
- A significant increase in Grade II and III disabilities was observed during MDT.
- Delayed initiation of MDT after disease onset was a key factor in high disability rates.
- Regular disability examinations were not consistently performed.
Conclusions:
- MDT alone did not prevent disability progression in the observed cohort.
- Timely disability assessment and prompt MDT initiation are crucial for mitigating leprosy-related disabilities.
- The findings underscore the importance of integrated care within leprosy control programs.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Antiprotozoal Agents
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Leishmaniasis
Rocky Mountain Spotted Fever
